FOI release

Inspection report request

This request was refused in part, so we didn't provide some of the information the requester asked for. This may include information where we can neither confirm nor deny that we hold it.

Case reference FOI2026/00378

Received 7 April 2026

Published 2 June 2026

Request

Could you please provide copies of the MHRA Good Clinical Practice (GCP) inspection reports relating to the following 3 inspections: Leo Pharma - Insp GCP 43/32961802-0002Takeda - Insp GCP 16189/19142243-0002GSK - Insp GCP 19494/37251014-0002 If any of the requested information is exempt from disclosure, I would be grateful if you could: • Provide the non-exempt information that can be disclosed, and • Clearly identify the exemption(s) relied upon for any information withheld.

Response

See attached

Documents

• FOI2026_00378 (redacted).pdf (887.0 KB)
• InspectionReport_Takeda_FINAL Redacted.pdf (1.6 MB)
• MHRA GCP Inspection Report GSK 22Dec2025 Closed_FINAL Redacted.pdf (697.6 KB)
• MHRA GCP Inspection_Leo_Final with statement 04Sept2025_FINAL Redacted.pdf (1.3 MB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.